Researcher Identifies Nearly 100 Studies Supporting Use Of Thermal Ablation To Treat Lung Cancer
9/02/2011
The journal Radiology will publish in its September issue an article written by Damian E. Dupuy, M.D., director of tumor ablation at Rhode Island Hospital, supporting the use of ablation procedures for the treatment of lung cancer...
Research Gives New Hope To Those With Rare Vascular Cancer
9/02/2011
A specific genetic alteration has been discovered as a defining feature of epithelioid hemangioendothelioma (EHE), a rare but devastating vascular cancer. These findings have also been used to develop a new diagnostic test for this blood vessel disease. An international research effort led by Brian Rubin, M.D., Ph.D...
Adjuvant Therapy Perhaps Not Necessary For Older Breast Cancer Patients
9/02/2011
Breast cancer patients over the age of 60 with early-stage, hormone-responsive small tumors who forego adjuvant endocrine, also called hormonal therapy, are not at an increased risk of mortality compared to women of the same age without breast cancer, according to a study published Aug. 31 in the Journal of the National Cancer Institute...
Stanford Scientists Discover Blood Factors That Appear To Cause Aging In Brains Of Mice
9/02/2011
In a study published Sept. 1 in Nature, Stanford University School of Medicine scientists have found substances in the blood of old mice that makes young brains act older. These substances, whose levels rise with increasing age, appear to inhibit the brain's ability to produce new nerve cells critical to memory and learning...
UF Medicinal Chemists Modify Sea Bacteria Byproduct For Use As Potential Cancer Drug
9/02/2011
University of Florida researchers have modified a toxic chemical produced by tiny marine microbes and successfully deployed it against laboratory models of colon cancer. Writing in ACS Medicinal Chemistry Letters, UF medicinal chemists describe how they took a generally lethal byproduct of marine cyanobacteria and made it more specifically toxic - to cancer cells...
Tiny Oxygen Generators Boost Effectiveness Of Anticancer Treatment
9/02/2011
Researchers have created and tested miniature devices that are implanted in tumors to generate oxygen, boosting the killing power of radiation and chemotherapy. The technology is designed to treat solid tumors that are hypoxic at the center, meaning the core contains low oxygen levels...
Scripps Research Scientists Reveal How White Blood Cell Promotes Growth And Spread Of Cancer
9/02/2011
Scientists at The Scripps Research Institute have shown that a particular white blood cell plays a direct role in the development and spread of cancerous tumors. Their work sheds new light on the development of the disease and points toward novel strategies for treating early-stage cancers. The study was published in September 2011 print issue of the American Journal of Pathology...
Implanted Sensor Chip To Monitor Tumor Growth
9/01/2011
Scientists in Germany are developing a microchip sensor that can be implanted near a tumor to monitor its growth aggressiveness, by sensing when oxygen levels in surrounding tissue drop, thus giving doctors and patients the opportunity to gauge when best to plan surgery or treatment...
How The Intricate Details Of Cells Work Better Understood, Potential For Cancer Treatment
9/01/2011
According to researchers at the University of Bath, UK, published on the 1st September in PLoS Genetics, a new approach to study cells has been discovered that offers a significantly better insight into how the intricate details of cells work. The findings could affect understanding and treatment of many diseases at cell level caused when cells start to function incorrectly, including cancer...
Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") announced that the independent Data Safety Monitoring Board (DSMB) for the pivotal Phase 3 X-PECT study of perifosine in patients with refractory advanced colorectal cancer has completed a pre-specified interim analysis for safety and futility. The DSMB has recommended that the Phase 3 study continue to completion, as planned...